Hairy cell leukemia variant (HCLv) presents with high disease burden, lack of typical
antigens like CD25, and poor response to standard treatments like cladribine. Occasionally, …

To compare hairy cell leukemia (HCL) with chronic lymphocytic leukemia (CLL) and normal
B cells with respect to their B-cell receptors, somatic hypermutation (SHM) features in HCL …

To examine the usage and mutational status of VH genes in hairy cell leukaemia (HCL), we
analysed 24 immunoglobulin heavy chain (IgH) sequences expressed in 23 patients. None …

… In this equation: N 0 , is the T cell count at the outset (for the calculations … at t = 1); N t , is
the T cell count at time t following transplant (t modeled as iterations); N t-1 represents the T cell …

… Author links open overlay panel Matthew Cowan a , Tara Suntum b , Andrea D. Olivas c , …
Tara Suntum: pediatric oncologist provided input on management of a second primary cervical …

… HLA-A24- and HLA-A2-restricted cytotoxic T cells against a melanoma surface antigen [1],
[2]… PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells…

Of 166 hairy cell leukemia (HCL) patients, 81 had kappa and 80 had lambda expression.
IGKV-J and IGLV-J rearrangement structure was analyzed in 21 HCL patients (11 kappa, 10 …

… Drs Suntum and Allen conceptualized and drafted the initial manuscript; Ms Pagano
drafted the initial case presentation of the manuscript; Dr Jaworski and Ms Duncan critically …

Aim: The aim of this study was to compare the efficacy and safety of a basal‐bolus insulin
regimen comprising either insulin detemir or neural protamine hagedorn (NPH) insulin in …

10–20% of patients with hairy cell leukemia (HCL) have a variant (HCLv) and present with
high tumor burden in spleen and peripheral blood, and are less responsive to purine analogs. …